Methylprednisolone Not Yet Recruiting Phase 2 Trials for Acute GvHD Prevention

IndicationsStatusPurposePhase
Not Yet RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03701698Ruxolitinib and Steroid as First Line Therapy for Acute GVHD